HerKare
HerKare is a Texas-based women's healthcare clinic network operating 5 locations that delivers bioidentical hormone replacement therapy, medically guided weight loss programs including GLP-1 medications, and comprehensive women's wellness services targeting perimenopause, menopause, and hormonal imbalances.
- Company typePrivate
- Founded2009
- HeadquartersSouthlake, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What HerKare does
HerKare is a Texas-based women's healthcare clinic network founded in 2009 and operated under parent company SynergenX Health Holdings, LLC. The company specializes in bioidentical hormone replacement therapy (HRT), addressing symptoms of perimenopause, menopause, thyroid deficiency, and other hormonal imbalances in women, with additional offerings in medically guided weight loss (including GLP-1 medications such as semaglutide and tirzepatide), peptide therapy, PT-141 for sexual health, glutathione injections, and at-home sleep testing. Its clinical approach combines a 65+ biomarker hormone panel with lipid and metabolic panels, Autonomic Nervous System (ANS) testing, and InBody body composition scans to support individualized treatment planning, with bioidentical hormones delivered via pills, topical creams, pellets, injections, and suppositories.
The company operates five clinic locations in Texas — four in the Dallas-Fort Worth metroplex (Frisco, Fort Worth, Mansfield, Southlake) and one in The Woodlands — supplemented by telehealth visits and the SynergenX mobile app for iOS and Android, which enables appointment booking, digital check-in, lab results review, supplement ordering, telemedicine, and medication reminders. HerKare accepts 12+ major insurance plans and offers self-pay options (including a $99 discounted hormone testing panel), with HSA/FSA eligibility. The company is led by CEO Wayne Wilson and is currently transitioning to the SynergenX brand alongside Low T Centers over a roughly 12-month horizon, consolidating women's and men's hormone therapy under a single national brand identity.
Revenue is generated through recurring insurance-reimbursed and self-pay clinical visits, ongoing HRT prescriptions, weight loss program enrollment, and ancillary wellness services. The business model combines subscription-like recurring revenue from long-term HRT patients with one-time diagnostic and consult fees. The company is privately held with no disclosed funding rounds, revenue figures, or external PE/VC ownership signals in the available source data.
HerKare firmographics
Firmographics- Name
- HerKare
- Legal name
- SynergenX Health Holdings, LLC
- Website
- https://herkare.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- HerKare is a Texas-based women's healthcare clinic network operating 5 locations that delivers bioidentical hormone replacement therapy, medically guided weight loss programs including GLP-1 medications, and comprehensive women's wellness services targeting perimenopause, menopause, and hormonal imbalances.
- Ownership category
- akta.pro rank
HerKare industry classification
Industry- Product category
- Women's Hormone Therapy and Wellness Services
- NAICS
- Other Ambulatory Health Care Services (6219)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Gynecology (General Non-Obstetric Care) (HLAKAJAL)
- akta.pro secondary industries
- Obstetrics & Gynecology (OB/GYN) Clinics (HLAFAJAA), Sexual & Pelvic Health Telehealth (STI care, pelvic pain, endometriosis/PCOS support) (HLALAHAJ)
Keywords
Where HerKare is headquartered
LocationHeadquarters
- HQ city
- Southlake
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
HerKare business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Insurance-Covered Healthcare Services: HerKare accepts major insurance plans including Aetna, Blue Cross Blue Shield, Cigna PPO, UnitedHealthcare, GEHA, Medical Mutual of Ohio, Meritain Health, APWU Health Plan, HealthPartners of Minnesota, and others. Services covered may include HRT, peptide therapy, GLP-1 weight loss medications, and lab monitoring.
- Self-Pay Services: Self-pay options available for patients without insurance coverage, including discounted hormone testing at $99 (reduced from $200)
- Hormone Replacement Therapy: Ongoing HRT treatments including estrogen, progesterone, and testosterone therapy through various delivery methods (pills, creams, pellets, injections, suppositories)
- Weight Loss Programs: Medically guided weight loss programs including GLP-1 medications (Semaglutide, Tirzepatide), oral medications, and combination programs
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Hybrid | Pay-as-you-go | Comprehensive Hormone Testing - Insurance or Self-Pay |
| Subscription | Monthly | Insurance-Covered Services |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels4 records
HerKare product offering
Product offeringCore offering
HerKare operates a network of women's healthcare clinics delivering bioidentical hormone replacement therapy (estrogen, progesterone, testosterone) through multiple delivery methods (pills, creams, pellets, injections, suppositories), medically guided weight loss programs featuring GLP-1 medications, and comprehensive diagnostic hormone testing. The company also offers ancillary women's wellness services including peptide therapy, thyroid treatment, PT-141 for sexual health, and glutathione injections, delivered through 5 Texas clinic locations and telehealth channels.
Product overview
HerKare is a women's healthcare clinic network providing specialized hormone health and wellness services across Texas. The company operates a platform-plus-services model offering bioidentical hormone replacement therapy (including estrogen, progesterone, and testosterone replacement in pills, creams, pellets, and injections), medically guided weight loss programs (featuring GLP-1 medications like semaglutide and tirzepatide in both injectable and oral dissolvable forms), comprehensive diagnostic testing (65+ biomarker hormone panels, ANS testing, InBody scans), women's wellness services (peptide therapy, menopause care, vitamin optimization, glutathione injections), and FDA-approved treatments like PT-141 for sexual health. Services are delivered through 5 Texas clinic locations and a proprietary SynergenX mobile app enabling appointment booking, telehealth visits, and patient engagement. The company is transitioning to the SynergenX brand while maintaining its focus on personalized, medically guided women's healthcare.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 80% of women experience hormonal imbalance
Companies that use HerKare
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
HerKare technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
HerKare partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- SynergenXcoreHerKare is transitioning to the SynergenX brand. Over the next year, HerKare clinics along with Low T Centers across the country will slowly transition to the SynergenX brand. The transition reflects continued growth of a company focused on personalized, medically guided care. HerKare and Low T Centers operate under the same parent company, SynergenX Health Holdings, LLC.
Scale indicators2 records
Recent moves7 records
Expansion highlights5 records
HerKare competitors and assessment
Company assessmentDirect peers
- Evernow: Telehealth platform focused on menopause and perimenopause care, providing HRT prescriptions and ongoing virtual care — overlaps HerKare's core menopause and hormonal imbalance offerings.
- Elektra Health: Women's menopause care platform combining virtual clinician visits with education and community — serves the same perimenopause/menopause patient segment as HerKare.
- Tia: Women's health clinic network offering in-person and virtual care including gynecology and hormonal care — comparable as a clinic-plus-virtual women's health provider.
- Winona: Direct-to-consumer women's hormone therapy provider offering bioidentical HRT and telehealth consultations — closely parallels HerKare's bioidentical hormone focus and prescription delivery model.
- Midi Health: Virtual-first specialty clinic for women in perimenopause and menopause, offering HRT, weight management, and telehealth visits — directly competes with HerKare for the same patient demographic and service lines.
- Alloy Women's Health: Telehealth platform specializing in menopause treatment with prescription and OTC products — directly competes with HerKare's menopause and hormonal health services.
Broad incumbents
- Ro: Multi-specialty telehealth platform offering HRT, weight loss (including GLP-1s), and women's health services — competes on overlapping offerings as a broader DTC health incumbent.
- Hims & Hers Health: Public telehealth company offering broad women's health services including hormone and weight loss treatments — broad incumbent competing for the same digitally-native patients.
Emerging players
- Maven Clinic: Virtual women's and family health platform covering hormonal health, fertility, and perimenopause — adjacent competitor in the women's virtual care category.
- Parsley Health: Functional medicine practice focusing on root-cause diagnosis and complex women's health conditions including hormones — overlaps with HerKare's diagnostic-heavy, personalized approach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
HerKare social profiles
Digital presenceHerKare compliance and trust
Trust signalCompliance1 record
HerKare financial estimates
Financial estimateRevenue estimate
Valuation estimate
HerKare leadership team
Management profileNumber of profiles
Profiles4 records
HerKare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HerKare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HerKare
What does HerKare do?
HerKare operates a network of women's healthcare clinics delivering bioidentical hormone replacement therapy (estrogen, progesterone, testosterone) through multiple delivery methods (pills, creams, pellets, injections, suppositories), medically guided weight loss programs featuring GLP-1 medications, and comprehensive diagnostic hormone testing. The company also offers ancillary women's wellness services including peptide therapy, thyroid treatment, PT-141 for sexual health, and glutathione injections, delivered through 5 Texas clinic locations and telehealth channels.
Is HerKare a public or private company?
HerKare is a private company. It is classified as corporate owned and is currently operating.
When was HerKare founded?
HerKare was founded in 2009. It employs 51 to 100 people.
Where is HerKare based?
HerKare is headquartered in Southlake, United States, in the North America region.
How does HerKare make money?
Four revenue lines are on record. Insurance-Covered Healthcare Services are the primary driver. The others are self-Pay Services, hormone Replacement Therapy and weight Loss Programs.
Who are HerKare's main competitors?
Direct peers on record are Evernow, Elektra Health, Tia, Winona, Midi Health and Alloy Women's Health. Broad incumbents are Ro and Hims & Hers Health. Emerging players are Maven Clinic and Parsley Health.
Does HerKare have an API?
No public API is recorded for HerKare.
What industry is HerKare in?
HerKare's product category is Women's Hormone Therapy and Wellness Services. Its primary akta.pro industry code is HLAKAJAL, Gynecology (General Non-Obstetric Care), with a secondary code of HLAFAJAA, Obstetrics & Gynecology (OB/GYN) Clinics. Its NAICS code is 6219 and its SIC code is 8011.